Trigyn Techno. (TRIGYN)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Nearly debt-free balance sheet: Debt/Equity of 0.01, so financial distress risk is low.
• Trading at a small discount to book value (₹58.44 vs ₹59.43), giving some asset-based downside cushion.
• Decent recent growth: sales +24.78%, profit +26.02%, and PEG ~1.18; growth is not extremely expensive if sustained.
• Piotroski F-score of 7/9 suggests improving balance sheet and efficiency metrics.
• Promoter holding of 44.51% aligns management with minority shareholders.

Concerns

• Earning quality is extremely poor: the latest quarter's ₹258 Cr revenue yielded only ₹1 Cr net profit, implying a razor-thin net margin.
• Reported ROE of -2.48% and ROCE of just 4.17% are far below acceptable returns on capital.
• P/E of 29.93 is rich for such low current earnings, and the 0.00% dividend means no income while waiting.
• Stock has fallen from ₹102.40 to ₹58.44, raising the risk of a value trap if margin expansion does not happen.

AI Analysis

At ₹58.44, Trigyn trades just below its book value of ₹59.43 — that catches my Graham eye. With debt/equity of only 0.01, there is no balance-sheet pressure; the company can survive even if operations stumble. But survival is not enough. The latest quarter shows ₹258 crore of revenue converting into just ₹1 crore of net profit. Such a thin margin tells me this is a low-pricing-power IT services/consulting business, not a franchise with pricing power. Reported ROE is -2.48%, and ROCE is just 4.17%, well below what I demand for deploying capital. The P/E of 29.93 is therefore a premium for hopes, not for current earning quality. What looks better? Sales grew 24.78% and profit grew 26.02%; the Piotroski F-score of 7/9 implies improvements in profitability, leverage and efficiency. Promoter holding of 44.51% gives some comfort that owner and minority interests are roughly aligned. With PEG around 1.18, the growth is not absurdly priced if the 26% profit growth is durable. But "if" is the key word. Zero dividend yield means I receive nothing while waiting for the story to play out. Mr. Market has already cut the price from ₹102.40 to ₹58.44. At near book value, the asset cushion limits some downside, but the real return depends on turning these thin margins into a healthy, positive ROE. This is a potential turnaround, not a stalwart. I want to see at least a few quarters of respectable net margins, positive and improving ROE, and cash generation before committing. The balance sheet gives me patience, but only evidence of a genuinely better business will give me conviction.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer